NutriBand (NTRB) Interest Coverage Ratio Growth (3y) (2020 - 2026)
NutriBand (NTRB) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 7.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 62.93% |
| Jan 31, 2026 | 61.06% |
| Oct 31, 2025 | 51.25% |
| Jul 31, 2025 | 87.88% |
| Apr 30, 2025 | -114.57% |
| Jan 31, 2025 | 72.85% |
| Oct 31, 2024 | 66.27% |
| Jul 31, 2024 | 26.20% |
| Apr 30, 2024 | -26.85% |
| Jan 31, 2024 | -94.44% |
| Oct 31, 2023 | -510.94% |
| Jul 31, 2023 | 88.19% |
| Apr 30, 2023 | -86.66% |
| Jan 31, 2023 | 90.65% |
| Oct 31, 2022 | -191.45% |
| Jul 31, 2022 | -813.19% |
| Apr 30, 2022 | -133.61% |
| Jan 31, 2022 | -550.66% |
| Oct 31, 2021 | -329.81% |
| Jul 31, 2021 | -198.42% |